Physio2Perform
ActiveSummary
Physio2Perform has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €7,019 and a net result of €21,662. Equity is growing by about 49% per year across the filed financial years. Its solvency ranks better than 12% of 20,659 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
- Equity
- €7,019
- Profit
- €21,662
Why 91raises risk1 change of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 0.56, cash €28,297Figures for financial year 2025 (filed 31-08-2026)Show the evidence
Checked score
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 12% on solvency, 30% on liquidity, 58% on profitability and 93% on growth.
The bankruptcy probability was computed on 30-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 3 accounts on average 29 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
- Annual accounts filedfinancial year 2025 · micro…
- Back to profitnet €21,662
- Annual accounts filedfinancial year 2024 · micro…
Financials · financial year 2025, micro format
2025 annual accounts filed late (28 days) Filed on 28 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00459411.
2023 to 2025, 3 financial years
The operating result returns to profit in 2025: €24,221 after a loss of €12,158 in 2024, the highest result in the available series.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Peer companies
Historical observationOf the 2,157 companies that looked in July 2024 the way this one looks now, 3.0% went bankrupt within 24 months and 94.1% are still going.
- Micro
- 2 to 5 years old
- solvency under 10%
- a profit of 5% of the balance sheet or more
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 2,157 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | €161 | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1,131 | €12,944 | €14,449 | ▲ 11.6% |
| Other operating charges640/8 | €321 | €744 | €340 | ▼ 54.3% |
| Gross operating margin9900 | -€3,455 | €1,692 | €39,010 | ▲ 23× |
| Operating profit (loss)9901 | -€4,906 | -€12,158 | €24,221 | - |
| Financial income75/76B | - | €3 | - | - |
| Recurring financial income75 | - | €3 | - | - |
| Financial charges65/66B | €22 | €2,559 | €2,438 | ▼ 4.7% |
| Recurring financial charges65 | €22 | €2,559 | €2,438 | ▼ 4.7% |
| Profit (loss) for the period before taxes9903 | -€4,928 | -€14,714 | €21,783 | - |
| Income taxes67/77 | - | - | €121 | - |
| Profit (loss) for the period9904 | -€4,928 | -€14,714 | €21,662 | - |
| Profit (loss) for the period to be appropriated9905 | -€4,928 | -€14,714 | €21,662 | - |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Assets | ||||
| Total assets20/58 | €73,648 | €97,049 | €93,128 | ▼ 4.0% |
| Fixed assets21/28 | €41,867 | €70,985 | €60,257 | ▼ 15.1% |
| Tangible fixed assets22/27 | €41,867 | €70,985 | €60,257 | ▼ 15.1% |
| Land and buildings22 | €29,925 | €45,543 | €36,740 | ▼ 19.3% |
| Plant, machinery and equipment23 | €11,942 | €25,443 | €23,517 | ▼ 7.6% |
| Current assets29/58 | €31,781 | €26,063 | €32,871 | ▲ 26.1% |
| Amounts receivable within one year40/41 | - | €1,979 | €4,574 | ▲ 131% |
| Trade receivables40 | - | €479 | €3,695 | ▲ 671% |
| Other amounts receivable41 | - | €1,500 | €879 | ▼ 41.4% |
| Cash at bank and in hand54/58 | €31,781 | €24,084 | €28,297 | ▲ 17.5% |
| Equity and liabilities | ||||
| Total equity and liabilities10/49 | €73,648 | €97,049 | €93,128 | ▼ 4.0% |
| Equity10/15 | €72 | -€14,643 | €7,019 | - |
| Contributions10/11 | €5,000 | €5,000 | €5,000 | = |
| Profit (loss) carried forward14 | -€4,928 | -€19,643 | €2,019 | - |
| Amounts payable17/49 | €73,576 | €111,691 | €86,109 | ▼ 22.9% |
| Amounts payable after more than one year17 | €40,775 | €42,236 | €27,459 | ▼ 35.0% |
| Financial debts170/4 | €40,775 | €42,236 | €27,459 | ▼ 35.0% |
| Amounts payable within one year42/48 | €32,801 | €69,455 | €58,650 | ▼ 15.6% |
| Current portion of amounts payable after more than one year42 | €9,225 | €14,204 | €14,778 | ▲ 4.0% |
| Financial debts43 | - | €12,170 | €177 | ▼ 98.5% |
| Credit institutions430/8 | - | €12,170 | €177 | ▼ 98.5% |
| Trade debts44 | €10,575 | €3,982 | €4,557 | ▲ 14.5% |
| Suppliers440/4 | €10,575 | €3,982 | €4,557 | ▲ 14.5% |
| Other amounts payable47/48 | €13,001 | €39,099 | €39,139 | ▲ 0.1% |
| Line | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|
| Profit (loss) for the period9904 | -€4,928 | -€14,714 | €21,662 | - |
| + Depreciation and write-downs630 | €1,131 | €12,944 | €14,449 | ▲ 11.6% |
| Operating cash flow (approximation) | -€3,798 | -€1,770 | €36,111 | - |
| Investment in fixed assets (approximation) | - | -€42,062 | -€3,721 | ▲ 91.2% |
| Change in cash | - | -€7,696 | €4,213 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (3)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | micro format | 28-08-2026 | 2026-00459411 |
| 31-12-2024 | micro format | 29-08-2025 | 2025-00436577 |
| 31-12-2023 | micro format | 29-08-2024 | 2024-00391452 |
Similar companies · same sector, comparable size
Subsidies and aid
Flemish government
2023 · 1 entry · €102 awarded · €102 paidPublic contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Mandate history
- Board
| Name | Functions and periods |
|---|---|
| Jef JORIS |
|
| Roel CLAES |
|
Owners and capital
Capital and shareholders
- Roel CLAES founder
- Jef JORIS founder
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 11-04-2023 Incorporation · €5,000 · 100 shares
Group and network
Connections & network
2 current directorsThe network starts from this company’s directors. Other companies they run appear here as nodes.
History
On 6 April 2023, Physio2Perform was incorporated as a private limited company by two natural persons, with a starting capital of €5,000.12 In 2024 the registered office moved to Edegem.3 Of the 2 current board members, 2 have served since 2023.2 Total assets went from €73,648 in 2023 to €93,128 in 2025.4
Acts, filings and financial milestones
09-12
Gazette deed
Registered officeRegistered-office move3 facts ▸
- General meeting, 01-04-2024
- Registered-office move, Hazeschransstraat 27,2650 Edegem
- Other provision, “naam en hoedanigheid, voorzijde laatste bladzijde Luik B” (deed in Dutch)
11-04
Gazette deed
IncorporationAppointments: Roel CLAES (director) and Jef JORIS (director) · Founder · Kind of shares9 facts ▸
- Incorporation, “Physio2Perform” (deed in Dutch)
- Founder, Roel CLAES (and shareholder)
- Founder, Jef JORIS (and shareholder)
- Kind of shares, “één soort van aandeel” (deed in Dutch)
- Director appointment, Roel CLAES (director (not named in the articles))
- Director appointment, Jef JORIS (director (not named in the articles))
- Pre-incorporation commitments, ratification, “verrichtingen vóór de datum van de oprichtingsakte, voor rekening van deze vennootschap in oprichting en in haar naam” (deed in Dutch)
- Power of attorney, Stephane Van Roosbroeck
- Founding capital, €5,000
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 31 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
1 establishment unit
1 parcel
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 11013A0030/00T010 | Flanders | 338 m² | 1 · 294 m² | 11.4 m · 1 |
How the parcels are linked
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “Alle verrichtingen, die hetzij rechtstreeks, hetzij onrechtstreeks verband houden met kinesitherapie, oefentherapie en in het bijzonder het…” (deed in Dutch)
18 activities (deed in Dutch)
- Alle verrichtingen, die hetzij rechtstreeks, hetzij onrechtstreeks verband houden met kinesitherapie, oefentherapie en in het bijzonder het behandelen van aandoeningen door middel van massages, manuele technieken, relaxatietherapie, elektrotherapie, tape- en bandagetechniek, accupunctuur, osteopathie en pre- en postnatale begeleidingen
- Oprichting, uitbating, beheer en begeleiding van fitnesscentra, sauna, solaria en algemene inrichtingen voor sport en fysieke vorming
- Het geven van onderwijs, opleiding, training en coaching m.b.t. kinesitherapie en aanverwante technieken
- Ambulante revalidatieactiviteiten
- Overige menselijke gezondheidszorg
- Wedstrijdbegeleiding
- Preventieve training aan teams of individuen
- Performance training aan teams of individuen
- Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels
- Verkoop van voedingssupplementen
- Het publiceren van artikelen en boeken
- Het beheren en uitbaten van een groepspraktijk voor kinesisten en soortgelijke, aanvullende beroepen en diensten, dit in het algemeen en in de breedste zin
- Het verstrekken van advies en bijstand, zowel technisch als administratief en commercieel, aan alle vennootschappen en ondernemingen
- De voorbereiding, de opstelling en het afsluiten, zowel als mandataris als voor eigen rekening van alle mogelijke overeenkomsten voor openbare of particuliere werken of voor leveringen en het uitvoeren van alle verrichtingen die daarmee verband houden
- Het verlenen van adviezen van financiële, technische, commerciële of administratieve aard, en dit in de ruimste zin, met uitzondering van adviezen inzake beleggingen en geldplaatsingen; bijstand en diensten verlenen, rechtstreeks of onrechtstreeks, op het vlak van administratie en financiën, verkoop, productie en algemeen bestuur
- Onderneming in handelsbemiddeling
- Consultancy, opleiding, technische expertise en bijstand op voornoemde gebieden
- De controle op of het participeren in het bestuur van vennootschappen of ondernemingen door het opnemen van alle mogelijke mandaten binnen vennootschappen of ondernemingen
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaams Gewest, 2610 Antwerpen-Wilrijk, Pater Verbiststraat 1B” (deed in Dutch)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “Met of zonder beperking van duur, 2” (deed in Dutch)
Capital, shares and profit
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- One provision in the deed
- Profit allocationHow profit is distributed; a BV may only pay out after a balance-sheet and liquidity test.
- “Bestuursorgaan, helft van de jaarlijkse nettowinst gereserveerd en de andere helft uitgekeerd voor zover is voldaan aan de wettelijke…” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- “11. De jaarvergadering wordt gehouden in de zetel van de vennootschap of op iedere andere plaats aange-wezen in de oproe-ping, elk jaar de…” (deed in Dutch)